In a report released today, Terence Flynn from Morgan Stanley reiterated a Buy rating on Eli Lilly & Co (LLY – Research Report), with a ...

Trading for Eli Morgan was a good start, but more work should be done. Thomas Harrigan of MLB.com recently spoke about Chicago being a perfect fit for relief pitcher Carlos Estevez. He highlighted ...

Pressly waived his full no-trade clause to be a Cub, and he’ll join the likes of Porter Hodge, Tyson Miller and Eli Morgan in the back end of the bullpen. With the Cubs still interested in some ...

Eli Lilly's stock dipped due to cutting Q4 sales targets, despite a strong 2024 performance from Mounjaro and Zepbound. Click ...

The Cubs also signed added Eli Morgan, Cody Poteet, Matt Festa, Caleb Thielbar and Rob Zastryzny to their bullpen this offseason. Adbert Alzolay struggled as the Cubs’ closer last year before he ...

He's the third reliever to leave the AL Central champions this winter, following Eli Morgan and Nick Sandlin, who were both traded.

JPMorgan analyst Chris Schott says Eli Lilly’s (LLY) Q4 miss represents a buying opportunity as the company is positioned for strong growth in 2025. The company’s 2025 sales guidance ...